176 related articles for article (PubMed ID: 12499280)
1. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
[TBL] [Abstract][Full Text] [Related]
2. Schwann cell-conditioned medium inhibits angiogenesis.
Huang D; Rutkowski JL; Brodeur GM; Chou PM; Kwiatkowski JL; Babbo A; Cohn SL
Cancer Res; 2000 Nov; 60(21):5966-71. PubMed ID: 11085514
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
4. 'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
Liu S; Tian Y; Chlenski A; Yang Q; Salwen HR; Cohn SL
Cancer Lett; 2005 Oct; 228(1-2):125-31. PubMed ID: 15935552
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
6. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth.
Hatzi E; Murphy C; Zoephel A; Rasmussen H; Morbidelli L; Ahorn H; Kunisada K; Tontsch U; Klenk M; Yamauchi-Takihara K; Ziche M; Rofstad EK; Schweigerer L; Fotsis T
Oncogene; 2002 May; 21(22):3552-61. PubMed ID: 12032857
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
9. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
10. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in neuroblastoma.
Ribatti D; Marimpietri D; Pastorino F; Brignole C; Nico B; Vacca A; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():133-42. PubMed ID: 15650239
[TBL] [Abstract][Full Text] [Related]
12. SPARC enhances tumor stroma formation and prevents fibroblast activation.
Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
[TBL] [Abstract][Full Text] [Related]
13. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
15. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.
Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS
Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.
Chlenski A; Guerrero LJ; Peddinti R; Spitz JA; Leonhardt PT; Yang Q; Tian Y; Salwen HR; Cohn SL
Mol Cancer; 2010 Jun; 9():138. PubMed ID: 20525313
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
18. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
[TBL] [Abstract][Full Text] [Related]
19. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
20. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
